Pune, India -- (SBWIRE) -- 03/06/2018 -- The Global Active B12 Test market is showing the moderate growth; mainly due to increase in the population suffering with B12 deficiency. Rising the patient suffering with dementia, Huntington's disease, and epilepsy are the leading causes of upward movement of active B12 test. According to report published by World Health Organization (WHO) in 2017, around 50 million people are suffering with dementia and around 10 million new cases of dementia are diagnosis each year.

The Global Active B12 Test Market is expected to grow at a CAGR of 7.2% during the forecast period and is estimated to reach USD 220 million by 2023.

Companies are showing much interest toward the market of active B12 Test, as they feel there are huge opportunities and gaps between the market demand and supply of active B12 Test market. Thus, companies are showing more interest in research and development activities for introducing the best procedure that meets the requirement of market. The development has been made by Axis-Shield Diagnostics Ltd. In Sep 2014, will develop the Active-B12 test for Siemens Healthcare allowing more laboratories worldwide to perform the test.

The companies are introducing better technology for getting the global leadership in the Active B12 Test market. Increasing in the prevalence of vitamin deficiency disease and neurological disorders around the globe is creating the huge scope for the market players to make a profit.

Get a Brochure of This Report @ https://www.marketresearchfuture.com/sample_request/4199 .

Key Player:

Some of the leading players at the cutting edge of the competition in the market of Active B12 Test globally.

Axis-Shield Diagnostics Ltd. (U.S.),
Abbott (U.S.),
Siemens Healthcare Private Limited (U.S.),
DiaSorin S.p.A. (Italy),
LifeSpan BioSciences Inc. (U.S.),
Demeditec Diagnostics GmbH (Germany)

Global Active B12 Test Market - Regional Analysis

According to report published by Alzheimer's Disease International (ADI), in 2015, around 46.8 million people globally have dementia and it is projected to be around 74.7 million in 2030 and 131.5 million in 2050. Also, according to report published by WHO in 2017, around 50 million people are suffering with epilepsy globally.

The market of active B12 test is much higher in the Americas region. There are several factors for tremendous growth of the active B12 test market in this region such as wider acceptance of the technology, Major players belong from this region. According to report published by Alzheimer's Disease International (ADI), in 2015, around 4.8 million are suffering with dementia in North Americas.

Grab Attractive Discount @ https://www.marketresearchfuture.com/check-discount/4199 .

Europe is also consider huge market for active B12 test players, owing to present of huge patient population. Moreover countries in this region have well established health care structure. The population within the reason are more aware about the healthcare in comparison to other region like Asia Pacific and The Middle East and Africa.

… Continued


Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.